Tags

Type your tag names separated by a space and hit enter

Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
Urol Int 2008; 80(4):378-82UI

Abstract

INTRODUCTION

Lower urinary tract symptoms (LUTS) are common in men over 50 years of age due to prostate enlargement. Diabetes mellitus is also more prevalent in this group. LUTS may result from bladder outlet obstruction (BOO) secondary to prostate enlargement or bladder dysfunction secondary to diabetes or even from a combination of both.

OBJECTIVES

The objective of this study was to determine the prevalence of BOO and other urodynamic abnormalities in diabetic patients with LUTS and enlarged prostate. A secondary objective was to assess the predictive value of non-invasive tests for BOO diagnosis in this group of patients.

PATIENTS AND METHODS

50 consecutive diabetic patients with enlarged prostate and LUTS were evaluated by the International Prostate Symptom Score (IPSS), ultrasonography and urodynamics. BOO diagnosis was based on pressure/flow measurements according to the International Continence Society's standards.

RESULTS

Of the 50 patients in the study, 23 (46%) had BOO. There was no correlation between the IPSS, uroflowmetry, post-voiding residual urine or prostate volume and the presence of BOO (p > 0.05).

CONCLUSIONS

There is a relatively low prevalence of BOO in diabetic patients with prostate enlargement and LUTS. Non-invasive tests did not allow the identification of these subjects. Only urodynamic evaluation is able to determine symptom etiology.

Authors+Show Affiliations

Division of Urology, University of São Paulo School of Medicine, São Paulo, Brazil.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18587248

Citation

Dib, Paulo Tadeu, et al. "Urodynamic Evaluation in Diabetic Patients With Prostate Enlargement and Lower Urinary Tract Symptoms." Urologia Internationalis, vol. 80, no. 4, 2008, pp. 378-82.
Dib PT, Trigo-Rocha F, Gomes CM, et al. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms. Urol Int. 2008;80(4):378-82.
Dib, P. T., Trigo-Rocha, F., Gomes, C. M., & Srougi, M. (2008). Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms. Urologia Internationalis, 80(4), pp. 378-82. doi:10.1159/000132695.
Dib PT, et al. Urodynamic Evaluation in Diabetic Patients With Prostate Enlargement and Lower Urinary Tract Symptoms. Urol Int. 2008;80(4):378-82. PubMed PMID: 18587248.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms. AU - Dib,Paulo Tadeu, AU - Trigo-Rocha,Flavio, AU - Gomes,Cristiano Mendes, AU - Srougi,Miguel, Y1 - 2008/06/27/ PY - 2007/04/04/received PY - 2007/06/19/accepted PY - 2008/7/1/pubmed PY - 2008/8/1/medline PY - 2008/7/1/entrez SP - 378 EP - 82 JF - Urologia internationalis JO - Urol. Int. VL - 80 IS - 4 N2 - INTRODUCTION: Lower urinary tract symptoms (LUTS) are common in men over 50 years of age due to prostate enlargement. Diabetes mellitus is also more prevalent in this group. LUTS may result from bladder outlet obstruction (BOO) secondary to prostate enlargement or bladder dysfunction secondary to diabetes or even from a combination of both. OBJECTIVES: The objective of this study was to determine the prevalence of BOO and other urodynamic abnormalities in diabetic patients with LUTS and enlarged prostate. A secondary objective was to assess the predictive value of non-invasive tests for BOO diagnosis in this group of patients. PATIENTS AND METHODS: 50 consecutive diabetic patients with enlarged prostate and LUTS were evaluated by the International Prostate Symptom Score (IPSS), ultrasonography and urodynamics. BOO diagnosis was based on pressure/flow measurements according to the International Continence Society's standards. RESULTS: Of the 50 patients in the study, 23 (46%) had BOO. There was no correlation between the IPSS, uroflowmetry, post-voiding residual urine or prostate volume and the presence of BOO (p > 0.05). CONCLUSIONS: There is a relatively low prevalence of BOO in diabetic patients with prostate enlargement and LUTS. Non-invasive tests did not allow the identification of these subjects. Only urodynamic evaluation is able to determine symptom etiology. SN - 1423-0399 UR - https://www.unboundmedicine.com/medline/citation/18587248/Urodynamic_evaluation_in_diabetic_patients_with_prostate_enlargement_and_lower_urinary_tract_symptoms_ L2 - https://www.karger.com?DOI=10.1159/000132695 DB - PRIME DP - Unbound Medicine ER -